.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
Teva
McKinsey
US Department of Justice
Julphar
Johnson and Johnson
Cerilliant
Express Scripts
US Army
UBS

Generated: September 23, 2017

DrugPatentWatch Database Preview

Patent Applications for hydrochlorothiazide; spironolactone

« Back to Dashboard

US Patent Applications for hydrochlorothiazide; spironolactone

US Patent Application Patent No. Title Patent Filing Date Patent Application Status Status Updated
► Subscribe► SubscribeTREATMENT OF CONDITIONS THROUGH MODULATION OF THE AUTONOMIC NERVOUS SYSTEM2004-06-18Patented Case2008-04-02
► Subscribe► SubscribeTreatment of conditions through pharmacological modulation of the autonomic nervous system2003-12-29Abandoned -- Failure to Respond to an Office Action2013-02-04
► Subscribe► SubscribeTreatment of conditions through modulation of the autonomic nervous system2004-10-07Abandoned -- Failure to Respond to an Office Action2015-11-29
► Subscribe► SubscribeTREATMENT OF CONDITIONS THROUGH MODULATION OF THE AUTONOMIC NERVOUS SYSTEM2005-02-16Patented Case2010-05-26
► Subscribe► SubscribeTREATMENT OF CONDITIONS THROUGH MODULATION OF THE AUTONOMIC NERVOUS SYSTEM DURING AT LEAST ONE PREDETERMINED MENSTRUAL CYCLE PHASE2004-05-13Patented Case2011-02-09
► Subscribe► SubscribeMethods of treating a subject for a condition2004-08-11Patented Case2013-10-09
► Subscribe► SubscribeMethods and compositions for treating a renal disease condition in a subject2006-11-01Advisory Action Mailed2016-11-08
► Subscribe► SubscribeMethod for treating resistant hypertension2006-08-24Abandoned -- Failure to Respond to an Office Action2010-06-30
► Subscribe► SubscribeANTIHYPERTENSIVE THERAPY METHOD2007-06-12Abandoned -- Failure to Respond to an Office Action2011-01-27
► Subscribe► SubscribeTHERAPY FOR COMPLICATIONS OF DIABETES2008-08-22Abandoned -- Failure to Respond to an Office Action2015-11-12
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Baxter
Dow
Federal Trade Commission
Johnson and Johnson
McKinsey
Cipla
Julphar
Fish and Richardson
Citi
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot